In last trading session, Hookipa Pharma Inc (NASDAQ:HOOK) saw 62764.0 shares changing hands with its beta currently measuring 0.69. Company’s recent per share price level of $2.48 trading at $0.16 or 6.90% at ring of the bell on the day assigns it a market valuation of $24.54M. That closing price of HOOK’s stock is at a discount of -355.65% from its 52-week high price of $11.30 and is indicating a premium of 16.13% from its 52-week low price of $2.08. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 89440.0 shares which gives us an average trading volume of 42.73K if we extend that period to 3-months.
For Hookipa Pharma Inc (HOOK), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.97 in the current quarter.
Hookipa Pharma Inc (NASDAQ:HOOK) trade information
Upright in the green during last session for gaining 6.90%, in the last five days HOOK remained trading in the red while hitting it’s week-highest on Thursday, 11/21/24 when the stock touched $2.48 price level, adding 9.82% to its value on the day. Hookipa Pharma Inc’s shares saw a change of -69.38% in year-to-date performance and have moved -8.82% in past 5-day. Hookipa Pharma Inc (NASDAQ:HOOK) showed a performance of -33.51% in past 30-days. Number of shares sold short was 36244.0 shares which calculate 1.08 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 3 to the stock, which implies a rise of 17.33% to its current value. Analysts have been projecting 3 as a low price target for the stock while placing it at a high target of 3. It follows that stock’s current price would drop -20.97% in reaching the projected high whereas dropping to the targeted low would mean a loss of -20.97% for stock’s current value.
Hookipa Pharma Inc (HOOK) estimates and forecasts
This year revenue growth is estimated to rise 142.70% from the last financial year’s standing.
3 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 5.01M for the same. Company posted 7.41M and 36.6M of sales in current and next quarters respectively a year earlier.
In 2024, company’s earnings growth rate is likely to be around 71.63% while estimates for its earnings growth in next 5 years are of 14.50%.
Hookipa Pharma Inc (NASDAQ:HOOK)’s Major holders
Insiders are in possession of 21.44% of company’s total shares while institution are holding 37.16 percent of that, with stock having share float percentage of 47.30%. Investors also watch the number of corporate investors in a company very closely, which is 37.16% institutions for Hookipa Pharma Inc that are currently holding shares of the company. ECOR1 CAPITAL, LLC is the top institutional holder at HOOK for having 5.72 million shares of worth $3.38 million. And as of 2024-06-30, it was holding 4.5597 of the company’s outstanding shares.
The second largest institutional holder is ARTAL GROUP S.A., which was holding about 5.67 million shares on 2024-06-30. The number of shares represents firm’s hold over 4.5191 of outstanding shares, having a total worth of $3.35 million.
